Developer docs
API playgroundTry for free, no card

Search company profiles

Oak HC/FT

Full company profile

uuid00000do

Namestring
Oak HC/FT
Legal namestring
Oak HC/FT
Websiteurl
oakhcft.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Oak HC/FT is a venture and growth equity investment firm founded in 2014 that specializes in two sectors: healthcare and financial services technology (fintech). The firm invests across the full company lifecycle, from early-stage through growth-stage, with approximately 120 portfolio investments, 52 portfolio realizations (exits), and 41 companies that have reached $1B+ valuations. Oak HC/FT manages $7B+ in assets under management, with its latest fund of nearly $2 billion raised in March 2026 maintaining similar scale to its $1.94 billion 2022 predecessor fund. The firm differentiates through decades-deep sector networks and a stated focus on five levers of structural change: Access, Outcomes, Cost, Speed, and Friction. Notable portfolio companies include CareBridge, Devoted Health, Maven Clinic, Feedzai, Galileo, Rapyd, Cart.com, Fundamental, Chai Discovery, and Main Street Health.

Short descriptiontext

Oak HC/FT is a venture and growth equity firm founded in 2014 that invests across early and growth stages in healthcare and fintech companies, managing $7B+ in assets across approximately 120 portfolio investments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersStamford, United States
HQ citystring
Stamford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
growth equity investing, venture capital, healthcare investments, fintech investments, portfolio support services
Industry2 codes
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity
SECONDARYFSANACAA
Technology & Software Growth Equity
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Services-Engineering, Accounting, Research, Management8700
Product category
Growth Equity & Venture Capital Investment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund management fees and carried interest
TypeLicensing Royalties
Description

Oak HC/FT generates revenue through management fees charged on assets under management (approximately $7B+ AUM across its funds) and carried interest from successful portfolio company exits. The firm raised nearly $2 billion for its latest venture fund, maintaining a similar size to its $1.94 billion predecessor fund from 2022.

oakhcft.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Oak HC/FT is a private growth equity and venture capital firm that invests capital across early-stage and growth-stage companies in the healthcare and financial services technology sectors. The firm provides transformational capital, strategic guidance, talent recruitment, and go-to-market support to portfolio founders through their company's lifecycle, with approximately $7B+ in assets under management and 120 portfolio investments to date.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 41 portfolio companies have reached $1B+ valuation
+2 more records
Product overview1 text field

Oak HC/FT is a growth equity investment firm, not a product company. It does not offer its own products or services. The firm invests in healthcare and fintech companies, with a portfolio of approximately 120 companies spanning sectors including value-based care (CareBridge, Devoted Health, Main Street Health), virtual health (Maven Clinic, Galileo), commerce and logistics (Cart.com), payments (Rapyd, Spade), fraud detection (Feedzai), and various AI-powered healthcare and fintech platforms. The firm's offerings are investment capital, strategic guidance, and network access to portfolio companies, rather than standalone product offerings.

Product and service3 records
1Oak HC/FT Latest Venture Fund (Fund V)
CategoryGrowth Equity / Venture Capital Fund
Description

Limited partners commit capital to Oak HC/FT's growth equity and venture fund vehicle, which deploys capital across early-stage to growth-stage healthcare and fintech companies.

2Oak HC/FT Predecessor Venture Fund (Fund IV)
CategoryGrowth Equity / Venture Capital Fund
Description

The 2022 vintage growth equity and venture fund from Oak HC/FT investing in healthcare and fintech companies, deployed across the firm's portfolio.

3Portfolio Operating Support (Talent, Go-to-Market, Network)
CategoryPortfolio Support Services
Description

Operating platform provided to Oak HC/FT portfolio companies, including an integrated talent team that has placed 45+ executives and provided 400+ annual candidate introductions, go-to-market support, and network access across healthcare and fintech sectors.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Long-standing growth equity firm with deep healthcare and financial services franchises, very similar multi-stage investing approach and a comparable track record of backing healthcare/fintech leaders.

TypeDirect peer
Description

Large venture capital firm with a heritage healthcare practice and growing fintech exposure, comparable in deploying multi-stage capital into healthcare and financial services startups.

TypeDirect peer
Description

Growth-stage investment firm with a scaled software/fintech focus and a large, recently raised fund, comparable to Oak HC/FT's growth equity orientation in fintech and tech-enabled healthcare.

TypeDirect peer
Description

Multi-stage venture and growth equity investor with dedicated healthcare and fintech practices, sharing a similar playbook of leading large rounds and supporting portfolio companies operationally.

TypeDirect peer
Description

Major venture firm with explicit bio/healthcare and fintech franchises, overlapping directly with Oak HC/FT in leading AI-driven healthcare and fintech rounds (e.g., co-investor in Rillet, Chai Discovery).

TypeDirect peer
Description

Global growth equity firm with significant healthcare and fintech/financial services practices, comparable multi-stage mandate and similar profile of large lead investments in category-defining companies.

TypeBroad incumbent
Description

Large alternative asset manager with a substantial healthcare and growth equity practice; competes for similar large healthcare/fintech growth rounds but with a much broader industry mandate.

TypeBroad incumbent
Description

Global alternative asset manager with growth equity and healthcare strategies; overlaps in healthcare services and fintech investing, but operates at a much larger and more diversified scale.

TypeEmerging player
Description

Venture firm with a strong heritage healthcare focus and select fintech exposure; comparable in vertical depth but typically smaller fund size than Oak HC/FT's vehicles.

TypeEmerging player
Description

Growth-stage investment firm with significant healthcare and fintech activity (co-led Rillet's Series B with a16z), overlapping in lead-investor roles in AI-native fintech and SaaS deals.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment192 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Oak HC/FT

Growth Equity & Venture Capital Investmentoakhcft.com

Oak HC/FT is a venture and growth equity firm founded in 2014 that invests across early and growth stages in healthcare and fintech companies, managing $7B+ in assets across approximately 120 portfolio investments.

What Oak HC/FT does

Oak HC/FT is a venture and growth equity investment firm founded in 2014 that specializes in two sectors: healthcare and financial services technology (fintech). The firm invests across the full company lifecycle, from early-stage through growth-stage, with approximately 120 portfolio investments, 52 portfolio realizations (exits), and 41 companies that have reached $1B+ valuations. Oak HC/FT manages $7B+ in assets under management, with its latest fund of nearly $2 billion raised in March 2026 maintaining similar scale to its $1.94 billion 2022 predecessor fund. The firm differentiates through decades-deep sector networks and a stated focus on five levers of structural change: Access, Outcomes, Cost, Speed, and Friction. Notable portfolio companies include CareBridge, Devoted Health, Maven Clinic, Feedzai, Galileo, Rapyd, Cart.com, Fundamental, Chai Discovery, and Main Street Health.

Oak HC/FT firmographics

Firmographics
Name
Oak HC/FT
Legal name
Oak HC/FT
Website
https://oakhcft.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
Oak HC/FT is a venture and growth equity firm founded in 2014 that invests across early and growth stages in healthcare and fintech companies, managing $7B+ in assets across approximately 120 portfolio investments.
Ownership category
akta.pro rank

Oak HC/FT industry classification

Industry
Product category
Growth Equity & Venture Capital Investment
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity
SECONDARYFSANACAA
Technology & Software Growth Equity

Keywords

  • Growth equity investing
  • Venture capital
  • Healthcare investments
  • Fintech investments
  • Portfolio support services

Where Oak HC/FT is headquartered

Location

Headquarters

HQ city
Stamford
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Oak HC/FT business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

  1. Fund management fees and carried interest: Oak HC/FT generates revenue through management fees charged on assets under management (approximately $7B+ AUM across its funds) and carried interest from successful portfolio company exits. The firm raised nearly $2 billion for its latest venture fund, maintaining a similar size to its $1.94 billion predecessor fund from 2022.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Oak HC/FT product offering

Product offering

Core offering

Oak HC/FT is a private growth equity and venture capital firm that invests capital across early-stage and growth-stage companies in the healthcare and financial services technology sectors. The firm provides transformational capital, strategic guidance, talent recruitment, and go-to-market support to portfolio founders through their company's lifecycle, with approximately $7B+ in assets under management and 120 portfolio investments to date.

Product overview

Oak HC/FT is a growth equity investment firm, not a product company. It does not offer its own products or services. The firm invests in healthcare and fintech companies, with a portfolio of approximately 120 companies spanning sectors including value-based care (CareBridge, Devoted Health, Main Street Health), virtual health (Maven Clinic, Galileo), commerce and logistics (Cart.com), payments (Rapyd, Spade), fraud detection (Feedzai), and various AI-powered healthcare and fintech platforms. The firm's offerings are investment capital, strategic guidance, and network access to portfolio companies, rather than standalone product offerings.

Differentiator

Problem solved

Functional benefit

Products and services

  • Oak HC/FT Latest Venture Fund (Fund V) Limited partners commit capital to Oak HC/FT's growth equity and venture fund vehicle, which deploys capital across early-stage to growth-stage healthcare and fintech companies.
  • Oak HC/FT Predecessor Venture Fund (Fund IV) The 2022 vintage growth equity and venture fund from Oak HC/FT investing in healthcare and fintech companies, deployed across the firm's portfolio.
  • Portfolio Operating Support (Talent, Go-to-Market, Network) Operating platform provided to Oak HC/FT portfolio companies, including an integrated talent team that has placed 45+ executives and provided 400+ annual candidate introductions, go-to-market support, and network access across healthcare and fintech sectors.

Quantifiable outcome

  • 41 portfolio companies have reached $1B+ valuation
  • +2 more outcomes

Companies that use Oak HC/FT

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Oak HC/FT technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Oak HC/FT partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Oak HC/FT competitors and assessment

Company assessment

Direct peers

  • Warburg Pincus: Long-standing growth equity firm with deep healthcare and financial services franchises, very similar multi-stage investing approach and a comparable track record of backing healthcare/fintech leaders.
  • New Enterprise Associates (NEA): Large venture capital firm with a heritage healthcare practice and growing fintech exposure, comparable in deploying multi-stage capital into healthcare and financial services startups.
  • Insight Partners: Growth-stage investment firm with a scaled software/fintech focus and a large, recently raised fund, comparable to Oak HC/FT's growth equity orientation in fintech and tech-enabled healthcare.
  • Bessemer Venture Partners: Multi-stage venture and growth equity investor with dedicated healthcare and fintech practices, sharing a similar playbook of leading large rounds and supporting portfolio companies operationally.
  • Andreessen Horowitz (a16z): Major venture firm with explicit bio/healthcare and fintech franchises, overlapping directly with Oak HC/FT in leading AI-driven healthcare and fintech rounds (e.g., co-investor in Rillet, Chai Discovery).
  • General Atlantic: Global growth equity firm with significant healthcare and fintech/financial services practices, comparable multi-stage mandate and similar profile of large lead investments in category-defining companies.

Broad incumbents

  • TPG Capital: Large alternative asset manager with a substantial healthcare and growth equity practice; competes for similar large healthcare/fintech growth rounds but with a much broader industry mandate.
  • KKR: Global alternative asset manager with growth equity and healthcare strategies; overlaps in healthcare services and fintech investing, but operates at a much larger and more diversified scale.

Emerging players

  • Venrock: Venture firm with a strong heritage healthcare focus and select fintech exposure; comparable in vertical depth but typically smaller fund size than Oak HC/FT's vehicles.
  • Iconiq Capital: Growth-stage investment firm with significant healthcare and fintech activity (co-led Rillet's Series B with a16z), overlapping in lead-investor roles in AI-native fintech and SaaS deals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Oak HC/FT social profiles

Digital presence

Oak HC/FT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Oak HC/FT leadership team

Management profile

Number of profiles

Profiles10 records

Oak HC/FT funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Oak HC/FT M&A and investment

M&A and investment

M&A

Investments192 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oak HC/FT

What does Oak HC/FT do?

Oak HC/FT is a private growth equity and venture capital firm that invests capital across early-stage and growth-stage companies in the healthcare and financial services technology sectors. The firm provides transformational capital, strategic guidance, talent recruitment, and go-to-market support to portfolio founders through their company's lifecycle, with approximately $7B+ in assets under management and 120 portfolio investments to date.

Is Oak HC/FT a public or private company?

Oak HC/FT is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Oak HC/FT founded?

Oak HC/FT was founded in 2014. It employs 51 to 100 people.

Where is Oak HC/FT based?

Oak HC/FT is headquartered in Stamford, United States, in the North America region.

How does Oak HC/FT make money?

One revenue line is on record: fund management fees and carried interest.

Who are Oak HC/FT's main competitors?

Direct peers on record are Warburg Pincus, New Enterprise Associates (NEA), Insight Partners, Bessemer Venture Partners, Andreessen Horowitz (a16z) and General Atlantic. Broad incumbents are TPG Capital and KKR. Emerging players are Venrock and Iconiq Capital.

Does Oak HC/FT have an API?

No public API is recorded for Oak HC/FT.

What industry is Oak HC/FT in?

Oak HC/FT's product category is Growth Equity & Venture Capital Investment. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523940 and its SIC code is 8700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogInaugural Future of Oncology Summit Brings Together Leaders to Accelerate Cancer InnovationThe inaugural Future of Oncology Summit took place November 9–10 in New Haven, bringing over 500 leaders from academia, biotech, pharma, and investment. Keynote speakers included ASCO CEO Clifford Hudis and Oak HC/FT's Annie Lamont, with discussions on AI, emerging therapies, and investment. The summit emphasized collaboration to accelerate cancer innovation.The SaaS NewsAlterra Labs Raises $12.5M SeedAlterra Labs, a New York-based startup, raised a $12.5 million seed round led by Oak HC/FT. The company will use the funds to build simulated medical environments and expand training services for AI labs and healthcare providers. The funding was announced on November 10, 2026.Crypto BriefingAlterra Labs raises $12.5 million seed round to train medical AI in simulated clinicsAlterra Labs, a New York startup, closed a $12.5 million seed round led by Oak HC/FT to build simulated clinical environments for testing AI models. The capital will expand its evaluation and training platform, with participation from Flare Capital Partners and Company Ventures.FortuneAlterra Labs announces $12.5 million seed round to test and train medical AIAlterra Labs, a New York startup, announced a $12.5 million seed round led by Oak HC/FT. The company builds simulated medical environments to test and train AI models, using clinician feedback to improve clinical judgment. Founder Akash Kapoor expects repeated testing and training as models gain capabilities.BitlyAlterra Labs raises $12.5M seed round.Alterra Labs raised a $12.5M seed round led by Oak HC/FT, with participation from Flare Capital, Company Ventures, Tau Ventures, and angels. The funding will accelerate research, grow its in-house team of clinicians, scientists, and researchers, and build partnerships with frontier AI organizations.LinkedInSurbhi Sarna - CollateVitalize announced a $31M Series A led by Oak HC/FT, with participation from Norwest Rock Health Capital, Constellation, and MemorialCare Innovation Fund. The company's labor operating system coordinates scheduling, staffing, and workforce planning for nearly 20 enterprise health systems, having made over 50 million staffing decisions.Tech TimesFinance AI Tops Out at 51% on Due Diligence: Startup Raises $30M to Fix ItHalluminate raised $30 million in a Series A led by Oak HC/FT, bringing total funding to $38.5 million. The company's benchmark shows top AI models score 51% on private-equity due diligence tasks. It plans to deepen work with frontier lab customers rather than expand to enterprise buyers.SourceryBREAKING: 7x Midas Investor Annie Lamont “90% Isn’t Worth It”Oak HC/FT closed Fund VI at nearly $2B, and Annie Lamont discussed AI drug discovery, China's 50% share of pharma research dollars, and Chai Discovery's $130M Series B. She said only 10% of companies justify valuations, and AI can cut 25-30% of healthcare administrative costs.PanewslabRWA周刊:ARK申请将Venture Fund份额上链和交易;美股代币化加速Robinhood Chain爆发RWA chain market cap reached $390.7 billion, with stablecoin monthly transfers up 49.44% and asset holders up 118.88%. ARK applied to tokenize Venture Fund shares, and Circle plans a $400 million acquisition of Tazapay. Regulatory approvals include Canada's OSFI and India's 620 billion-dollar bond tokenization pilot.CoinMarketCapStripe and Uber alumni raise $35 million to make stablecoins feel like local cash: Guest Post by CRYIPLatitude, a payments startup founded by alumni of Stripe and Uber, has raised $35 million in a Series A round led by Oak HC/FT, bringing its total funding to $43 million. The company’s product converts stablecoin payments into local currency payouts, allowing recipients to receive funds via traditional banking rails without needing to handle cryptocurrency directly. Investors including Coinbase Ventures, NEA, and Lightspeed Faction backed the venture as it positions stablecoins as invisible settlement infrastructure rather than requiring end-user crypto adoption.